$NRXP $RLFTF 3. The terms of the original March 2020 collaboration were simple: NeuroRx agreed to attempt to develop a generic drug ingredient, aviptadil, into an FDA-approvable drug that could be used to save lives; and Relief promised to fund the research and to compensate NeuroRx with 10% of Relief’s stock. From iapps.courts.state.ny.us/ny...
2